This data are also in accordance with a most recent review where authors reported that inhibition of the NF-κB signaling contributes to the anticancer effects of some therapeutic drugs to prevent colon cancer metastasis [41]. This evidence concerns the gene NFKB1 and malignant colon neoplasm.